Skip to main content
Signal8

3M CO (MMM)

3M Company operates as a global technology conglomerate with diverse interests. Its extensive operations are strategically divided into four primary business segments: Safety and Industrial, Transportation and Electronics, Health Care, and Consumer. The Safety and Industrial division supplies a broad array of products, including specialized abrasives and finishing tools for metalworking, automotive body repair kits, fastening systems for personal hygiene items, various masking and packaging materials, electrical components for construction, maintenance, and power distribution, strong structural adhesives and tapes, comprehensive personal protective equipment for respiratory, auditory, visual, and fall protection, and mineral granules for roofing shingles. Within the Transportation and Electronics sector, offerings encompass advanced ceramic solutions, specialized attachment tapes and films, sophisticated sound and temperature management systems for vehicles, high-quality large-format graphic films for advertising and fleet branding, optical films, electronic assembly solutions, robust packaging and interconnection technologies, and reflective materials crucial for highway and vehicle safety. The Health Care segment provides essential solutions such as food safety indicators, software for medical procedure coding and reimbursement, a wide range of products for skin and wound care, infection prevention, dental and orthodontic supplies, and advanced filtration and purification systems. Finally, the Consumer unit delivers an assortment of household and personal products, including bandages, braces, support devices, and personal respirators; various home cleaning supplies; retail-grade abrasives, paint accessories, DIY car care products, picture hanging solutions, and consumer-focused air quality improvements; along with a selection of stationery items. The company distributes its extensive product portfolio through both online platforms and a comprehensive traditional network, leveraging wholesalers, retailers, jobbers, distributors, and authorized dealers. This enterprise was founded in 1902 and maintains its corporate headquarters in St. Paul, Minnesota.

Sector: Surgical & Medical Instruments & Apparatus

Industry: Conglomerates

3M Company logo

3M Company

NYSE:MMMIndustrials
-1.70%$174.34
AH$174.34+0.00%vs close
Mkt Cap$90.09B
Float515.41M
O/S516.73M
Vol
$ Vol
RVOL
Inst Own73.5%
SI1.9%
Earnings
Div Yield1.76%
Dilution
Phase Distribution
12 lead-sponsored trials·0 active·6 completed
Phase 31
Not applicable11
(114 more as collaborator)
Status Overview
Completed6
Stopped5
Unknown1

Trials need funding. See this company's dilution risk and cash position.

Clinical Trials
Sponsor role
Status
Phase
  • Phase 3
    Completed

    In Vivo Efficacy Study of Patient Preoperative Preps

    3M CHG/IPA Prep C, 3M CHG/IPA Prep CH

    Bacterial Reduction Post-product Application

    Enrollment
    738
    Start
    Jul 2014
    Primary Completion
    Mar 2015
    Completion
    Mar 2015
    NCT02203591
  • Not applicable
    Completed

    SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds

    Traditional NPWT System, SNaP Wound Care System

    Ulcers, Wounds

    Enrollment
    132
    Start
    Jul 2009
    Primary Completion
    Mar 2011
    Completion
    Mar 2011
    NCT00951080
  • Not applicable
    Withdrawn

    Clinical Evaluation of the SNaP Wound Care System

    SNaP Wound Care System

    Acute and Chronic Wounds, Pressure Ulcers +3

    Enrollment
    0
    Start
    Mar 2010est.
    Primary Completion
    Apr 2014est.
    Completion
    Aug 2014est.
    NCT01113658
  • Observational
    Terminated

    Impact of Pre-surgical Nasal Bacterial Reduction on Postoperative Surgical Site Infections / Standard Care Change

    3M Skin and Nasal Antiseptic

    Surgical Site Infection

    Enrollment
    333
    Start
    Jun 2010
    Primary Completion
    Jul 2012
    Completion
    Jul 2012
    NCT01148030
  • Observational
    Completed

    Comparison Study of Core Temperature Thermometry Systems

    -

    Thermometry Device Comparisons

    Enrollment
    111
    Start
    Dec 2010
    Primary Completion
    Aug 2011
    Completion
    Dec 2011
    NCT01255865
  • Observational
    Completed

    Post-Market Clinical Evaluation of the Spiracur SNaP Wound Care System for Treatment of Acute Trauma and Acute Surgical Excision Wounds

    SNaP® Wound Care System

    Trauma-related Wound, Surgical Wound, Recent

    Enrollment
    30
    Start
    Jun 2011
    Primary Completion
    Oct 2012
    Completion
    Oct 2012
    NCT01417234
  • Observational
    Withdrawn

    Human Tissue Repository for Wound Care

    -

    Human Tissue Repository

    Enrollment
    0
    Start
    -
    Primary Completion
    -
    Completion
    -
    NCT01432054
  • Not applicable
    Completed

    Zero Heat Flux Thermometry System Comparison Trial

    Zero-heat-flux thermometry

    Body Temperature, Thermosensing +1

    Enrollment
    20
    Start
    Apr 2013
    Primary Completion
    Jun 2013
    Completion
    Jun 2013
    NCT01670760
  • Not applicable
    Withdrawn

    A Clinical Study to Assess a Compression Device in Patients With Venous Leg Ulcers

    3M™ Coban™ Custom Fit Compression System, Profore

    Varicose Ulcer

    Enrollment
    0
    Start
    Sep 2015
    Primary Completion
    Mar 2016est.
    Completion
    Mar 2016est.
    NCT02561013
  • Observational
    Unknown status

    EXD-959 Orthodontic Brackets and EXD-961 Related Instruments Trial

    EXD-959 Bracket System

    Malocclusion

    Enrollment
    78
    Start
    Jun 2018
    Primary Completion
    Dec 2021est.
    Completion
    Apr 2022est.
    NCT03606551
  • Not applicable
    Completed

    Clinical Study of Filtek™ Bulk Fill Posterior Restorative in Class I and II Restorations

    Filtek™ Bulk Fill Posterior Restorative, Filtek™ Z350XT Universal Restorative

    Dental Caries Class I, Dental Caries Class II

    Enrollment
    240
    Start
    Oct 2017
    Primary Completion
    Nov 2019
    Completion
    Nov 2019
    NCT03764059
  • Not applicable
    Terminated

    Evaluation of V.A.C. VERAFLO CLEANSE CHOICE™ Dressing Using Normal Saline to Promote Increased Healthy Wound Bed Tissue

    V.A.C. VERAFLO CLEANSE CHOICE™ dressing with Normal Saline

    Wound, Wound Heal +3

    Enrollment
    8
    Start
    Jul 2019
    Primary Completion
    Aug 2020
    Completion
    Aug 2020
    NCT04026334